Lucy Rowell

1.6k total citations
31 papers, 1.2k citations indexed

About

Lucy Rowell is a scholar working on Rheumatology, Immunology and Infectious Diseases. According to data from OpenAlex, Lucy Rowell has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 9 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Lucy Rowell's work include HIV/AIDS drug development and treatment (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Lucy Rowell is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Biosimilars and Bioanalytical Methods (7 papers). Lucy Rowell collaborates with scholars based in United Kingdom, United States and Switzerland. Lucy Rowell's co-authors include Gerd R Burmester, Min Bao, Stephen Hall, Charles Ludivico, Richard Kay, Eduardo Mysler, Daniel Feldman, Andrea Rubbert‐Roth, Katie Patel and Alain Cantagrel and has published in prestigious journals such as Gut, Antimicrobial Agents and Chemotherapy and Annals of the Rheumatic Diseases.

In The Last Decade

Lucy Rowell

31 papers receiving 1.1k citations

Peers

Lucy Rowell
Chan‐Bum Choi South Korea
Andrea Becciolini Italy
Ivânio Alves Pereira Brazil
Marwan Bukhari United Kingdom
Jerzy Świerkot Poland
M. P. M. van der Linden Netherlands
Niti Goel United States
Piotr Leszczyński Poland
Elena Massarotti United States
Rachel Knevel Netherlands
Chan‐Bum Choi South Korea
Lucy Rowell
Citations per year, relative to Lucy Rowell Lucy Rowell (= 1×) peers Chan‐Bum Choi

Countries citing papers authored by Lucy Rowell

Since Specialization
Citations

This map shows the geographic impact of Lucy Rowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Rowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Rowell more than expected).

Fields of papers citing papers by Lucy Rowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Rowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Rowell. The network helps show where Lucy Rowell may publish in the future.

Co-authorship network of co-authors of Lucy Rowell

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Rowell. A scholar is included among the top collaborators of Lucy Rowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Rowell. Lucy Rowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morcos, Peter N., Xiaoping Zhang, Christine McIntyre, et al.. (2013). Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20. International Journal of Clinical Pharmacology and Therapeutics. 51(7). 537–548. 19 indexed citations
3.
Phelan, Mary C., Judith Anzures‐Cabrera, David Carlile, et al.. (2013). Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib. Clinical Pharmacokinetics. 52(4). 255–265. 10 indexed citations
4.
Zhang, Xiao–Ping, et al.. (2013). Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 443–455. 40 indexed citations
5.
Zhang, Xiaoping, et al.. (2013). Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics. 52(1). 27–38. 6 indexed citations
6.
Zhang, Xiaoping, et al.. (2013). Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics. 51(8). 620–630. 21 indexed citations
7.
Bentley, Darren, et al.. (2012). Evidence of a Drug–Drug Interaction Linked to Inhibition of Ester Hydrolysis by Orlistat. Journal of Cardiovascular Pharmacology. 60(4). 390–396. 22 indexed citations
8.
Cooper, DA, Peter Reiss, Keith Henry, et al.. (2010). The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy*. HIV Medicine. 12(1). 31–39. 12 indexed citations
9.
Recker, Robert R., Bente Langdahl, E. J. Czerwiński, et al.. (2009). Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study. Bone. 46(3). 660–665. 22 indexed citations
10.
Rockstroh, Jürgen K., Edwin DeJesus, Cynthia Wat, et al.. (2008). Adherence to Enfuvirtide and Its Impact on Treatment Efficacy. AIDS Research and Human Retroviruses. 24(2). 141–148. 4 indexed citations
11.
Wright, David H., Eliot Godofsky, Sharon Walmsley, et al.. (2008). Efficacy and Safety of 48 Weeks of Enfuvirtide 180 mg Once-Daily Dosing Versus 90 mg Twice-Daily Dosing in HIV-Infected Patients. HIV Clinical Trials. 9(2). 73–82. 10 indexed citations
12.
Tebas, Pablo, Christopher Lucasti, Gary Richmond, et al.. (2008). Enfuvirtide Does Not Require Dose Adjustment in Patients With Chronic Kidney Failure. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(3). 342–345. 15 indexed citations
13.
Clotet, Bonaventura, Amedeo Capetti, Luis Enrique Soto-Ramírez, et al.. (2008). A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study. Journal of Antimicrobial Chemotherapy. 62(6). 1374–1378. 5 indexed citations
14.
Streinu‐Cercel, Adrian, Miguel Górgolas, Markus Müller, et al.. (2008). Switching from a Toxicity-Causing Antiretroviral to Enfuvirtide in Patients with HIV: The SWITCH TOX Study. HIV Clinical Trials. 9(6). 375–386. 3 indexed citations
15.
Wiznia, Andrew, Joseph A. Church, Patricia Emmanuel, et al.. (2007). Safety and Efficacy of Enfuvirtide for 48 Weeks as Part of an Optimized Antiretroviral Regimen in Pediatric Human Immunodeficiency Virus 1-Infected Patients. The Pediatric Infectious Disease Journal. 26(9). 799–805. 17 indexed citations
16.
Patel, Katie, Richard Kay, & Lucy Rowell. (2006). Comparing proportional hazards and accelerated failure time models: an application in influenza. Pharmaceutical Statistics. 5(3). 213–224. 69 indexed citations
17.
Jy, Reginster, S. Adámi, Péter L. Lakatos, et al.. (2005). Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Annals of the Rheumatic Diseases. 65(5). 654–661. 234 indexed citations
18.
Davé, Nisha, et al.. (2005). Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate. British Journal of Clinical Pharmacology. 59(5). 598–601. 32 indexed citations
19.
Thompson, Paul, et al.. (1990). Evaluation of a simple method for the measurement of cytidine deaminase in serum and comparison with a reference method. Clinica Chimica Acta. 192(1). 55–59. 4 indexed citations
20.
Glass, Richard E., A W Goode, B. J. Houghton, & Lucy Rowell. (1986). Plasma arginine in cancer of the gastrointestinal tract: effect of surgical treatment.. Gut. 27(7). 844–848. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chan‐Bum Choi Breakdown of academic impact, for papers by Andrea Becciolini Breakdown of academic impact, for papers by Ivânio Alves Pereira Breakdown of academic impact, for papers by Marwan Bukhari Breakdown of academic impact, for papers by Jerzy Świerkot Breakdown of academic impact, for papers by M. P. M. van der Linden Breakdown of academic impact, for papers by Niti Goel Breakdown of academic impact, for papers by Piotr Leszczyński Breakdown of academic impact, for papers by Elena Massarotti Breakdown of academic impact, for papers by Rachel Knevel
Rankless by CCL
2026